Signaling to life and death: Influenza viruses and intracellular signal transduction cascades

Monographs in Virology

Volumn 27, Issue , 2008, Pages 210-224

  Ludwig, Stephan ^a   Planz, Oliver ^b   Pleschka, Stephan ^c   Wolff, Thorsten ^d  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AVES; AVIAN INFLUENZA VIRUS; MAMMALIA; ORTHOMYXOVIRIDAE;

EID: 50549103805     PISSN: 00770965     EISSN: 16623851     Source Type: Book Series    
DOI: 10.1159/000151657     Document Type: Article

References (68)

1. Ludwig S, Pleschka S, Wolff T: A fatal relationship influenza virus interactions with the host cell. Viral Immunol 1999;12:175-196.
2. Samuel CE: Antiviral actions of interferons. Clin Microbiol Rev 2001;14:778-809.
3. Garcia-Sastre A, Biron CA: Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006;312:879-882.
4. Isaacs A, Lindenmann J: Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957;147:258-267.
5. Sekellick MJ, Lowenthal JW, O'Neil TE, Marcus PI: Chicken interferon types I and II enhance synergistically the antiviral state and nitric oxide secretion. J Interferon Cytokine Res 1998;18:407-414.
6. Staeheli P, Puehler F, Schneider K, Gobel TW, Kaspers B: Cytokines of birds: conserved functions a largely different look. J Interferon Cytokine Res 2001;21:993-1010.
7. Hwang SY, Hertzog PJ, Holland KA, Sumarsono SH, Tymms MJ, Hamilton JA, Whitty G, Bertoncello I, Kola I: A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons α and βand alters macrophage responses. Proc Natl Acad Sci USA 1995;92:11284-11288.
8. Garcia-Sastre A: Identification and characterization of viral antagonists of type I interferon in negativestrand RNA viruses. Curr Top Microbiol Immunol 2004;283:249-280.
9. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G: 5′-Triphosphate RNA is the ligand for RIG-I. Science 2006;314:994-997.
10. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006;441:101-105.
11. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C: RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006;314:997-1001.
12. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T: Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol Cell 1998;1:507-518.
13. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S: Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005;23:19-28.
14. Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C, Yamamoto M, Uematsu S, Ishii KJ, Takeuchi O, Akira S: Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 2006;203:1795-1803.
15. Hiscott J, Lin R, Nakhaei P, Paz S: MasterCARD: a priceless link to innate immunity. Trends Mol Med 2006;12:53-56.
16. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB:VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol Cell 2005;19:727-740.
17. Cauthen AN, Swayne DE, Sekellick MJ, Marcus PI, Suarez DL: Amelioration of influenza virus pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol 2007;81:1838-1847.
18. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T: Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 1998;252:324-330.
19. Kochs G, Koerner I, Thiel L, Kothlow S, Kaspers B, Ruggli N, Summerfield A, Pavlovic J, Stech J, Staeheli P: Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol 2007;88:1403-1409.
20. Li Z, Jiang Y, Jiao P, Wang A, Zhao F, Tian G, Wang X, Yu K, Bu Z, Chen H: The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. J Virol 2006;80:11115-11123.
21. Dauber B, Schneider J, Wolff T: Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of α/β interferon. J Virol 2006;80:11667-11677.
22. Donelan NR, Basier CF, Garcia-Sastre A: A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of β interferon and is attenuated in mice. J Virol 2003;77:13257-13266.
23. Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, Schmeck B, Hippenstiel S, Suttorp N, Wolff T: IFN-βinduction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 2007;9:930-938.
24. Hatada E, Saito S, Fukuda R: Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J Virol 1999;73:2425-2433.
25. Noah DL, Twu KY, Krug RM: Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. Virology 2003;307:386-395.
26. Dhand R, Hiles I, Panayotou G, Roche S, Fry MJ, Gout I, Totty NF, Truong O, Vicendo P, Yonezawa K, et al: FI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J 1994;13:522-533.
27. Neri LM, Borgatti P, Capitani S, Martelli AM: The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system. Biochim Biophys Acta 2002;1584:73-80.
28. Cooray S: The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J Gen Virol 2004;85:1065-1076.
29. Sarkar SN, Peters KL, Elco CP, Sakamoto S, Pal S, Sen GC: Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 2004;11:1060-1067.
30. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M: Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 2005;280:5571-5580.
31. Ehrhardt C, Marjuki H, Wolff T, Nürnberg B, Planz O, Pleschka S, Ludwig S: Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol 2006;8:1336-1348.
32. Ehrhardt C, WolffT, Pleschka S, Planz O, Beermann W, Bode JG, Schmolke M, Ludwig S: Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol 2007;81:3058-3067.
33. Shin YK, Liu Q, Tikoo SK, Babiuk LA, Zhou Y: Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation. J Gen Virol 2007;88:942-950.
34. Zhirnov OP, Klenk HD: Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Apoptosis 2007;12:1419-1432.
35. Ludwig S: Exploited defense - how influenza takes advantage of antiviral signaling responses. Future Virology 2007;2:91-100.
36. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE: Influenza A virus NS1 protein binds p85β and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci USA 2006;103:14194-14199.
37. Shin YK, Liu Q, Tikoo SK, Babiuk LA, Zhou Y: Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol 2007;88:13-18.
38. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH: Mitogen-activated protein kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:153-183.
39. Kujime K, Hashimoto S, Gon Y, Shimizu K, Horie T: p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells. J Immunol 2000;164:3222-3228.
40. Ludwig S, Ehrhardt C, Neumeier ER, Kracht M, Rapp UR, Pleschka S: Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J Biol Chem 2001;276:10990-10998.
41. Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S: Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat Cell Biol 2001;3:301-305.
42. Lee DC, Cheung CY, Law AH, Mok CK, Peiris M, Lau AS: p38 mitogen-activated protein kinasedependent hyperinduction of tumor necrosis factor ct expression in response to avian influenza virus H5N1. J Virol 2005;79:10147-10154.
43. Ludwig S, Wolff T, Ehrhardt C, Wurzer WJ, Reinhardt J, Planz O, Pleschka S: MEK inhibition impairs influenza B virus propagation without emergence of resistant variants. FEBS Lett 2004;561:37-43.
44. Olschlager V, Pleschka S, Fischer T, Rziha HJ, Wurzer W, Stitz L, Rapp UR, Ludwig S, Planz O: Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice. Oncogene 2004;23:6639-6646.
45. Dumitru CD, Ceci JD, Tsatsanis C, Kontoyiannis D, Stamatakis K, Lin JH, Patriotis C, Jenkins NA, Copeland NG, Kollias G, Tsichlis PN: TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 2000;103:1071-1083.
46. Marjuki H, Alam MI, Ehrhardt C, Wagner R, Planz O, Klenk HD, Ludwig S, Pleschka S: Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase C α-mediated activation of ERK signaling. J Biol Chem 2006:281:16707-16715.
47. Eisenberg S, Shvartsman DE, Ehrlich M, Henis YI: Clustering of raft-associated proteins in the external membrane leaflet modulates internal leaflet H-ras diffusion and signaling. Mol Cell Biol 2006;26:7190-7200.
48. Ludwig S, Planz O, Pleschka S, Wolff T: Influenza-virus-induced signaling cascades: targets for antiviral therapy? Trends Mol Med 2003;9:46-52.
49. Klumpp K: Recent advances in the discovery and development of anti-influenza drugs. Expert Opin Ther Pat 2004;14:1153-1168.
50. Planz O, Pleschka S, Ludwig S: MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells. J Virol 2001;75:4871-4877.
51. Sebolt-Leopold JS, Dudley DT, Herrera R, Van Becelaere K, Wiland A, Gowan RC, Tede H, Barrett SD, Bridges A, Przybranowski S, Leopold WR, Saltiel AR: Blodcade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med 1999;5:810-816.
52. Cohen P: Protein kinases - the major drug targets of the twenty-first century? Nat Rev Drug Discov 2002;1:309-315.
53. Pahl HL: Activators and target genes of Rel/NF-KB transcription factors. Oncogene 1999;18:6853-6866.
54. Hiscott J, Kwon H, Genin P: Hostile takeovers: viral appropriation of the NF- KB pathway. J Clin Invest 2001;107:143-151.
55. Bonizzi G, Karin M: The two NF-KB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004;25:280-288.
56. Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, Garcia-Sastre A: Influenza A virus NS1 protein prevents activation of NF-KB and induction of α/β interferon. J Virol 2000;74:11566-11573.
57. Wurzer WJ, Ehrhardt C, Pleschka S, Berberich-Siebelt F, Wolff T, Walczak H, Planz O, Ludwig S: NF-κB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem 2004;279:30931-30937.
58. Bemasconi D, Amici C, La Frazia S, Ianaro A, Santoro MG: The IκB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells. J Biol Chem 2005;280:24127- 24134.
59. Flory E, Kunz M, Scheller C, Jassoy C, Stauber R, Rapp UR, Ludwig S: Influenza virus-induced NF-κB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IκB kinase. J Biol Chem 2000;275:8307-8314.
60. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004;303:1526-1529.
61. Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, Yamamoto M, Terai K, Matsuda M, Inoue J, Uematsu S, Takeuchi O, Akira S: Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004; 5:1061-1068.
62. Chu WM, Ostertag D, Li ZW, Chang L, Chen Y, Hu Y, Williams B, Perrault J, Karin M: JNK2 and IKKβ are required for activating the innate response to viral infection. Immunity 1999;11:721-731.
63. Pahl HL, Baeuerle PA: Expression of influenza virus hemagglutinin activates transcription factor NF-κB. J Virol 1995;69:1480-1484.
64. Nimmerjahn F, Dudziak D, Dirmeier U, Hobom G, Riedel A, Schlee M, Staudt LM, Rosenwald A, Behrends U, Bornkamm GW, Mautner J: Active NF-κB signalling is a prerequisite for influenza virus infection. J Gen Virol 2004;85:2347-2356.
65. Bourteele S, Oesterle K, Pleschka S, Unterstab G, Ehrhardt C, Wolff T, Ludwig S, Planz O: Constitutive activation of the transcription factor NF-κB results in impaired borna disease virus replication. J Virol 2005;79:6043-6051.
66. Wurzer WJ, Planz O, Ehrhardt C, Giner M, Silberzahn T, Pleschka S, Ludwig S: Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J 2003;22:2717-2728.
67. Mazur I, Wurzer WJ, Ehrhardt C, Pleschka S, Puthavathana P, Silberzahn T, Wolff T, Planz O, Ludwig S: Acetylsalicylic acid blocks influenza virus propagation via its NF-κB-inhibiting activity. Cell Microbiol 2007;9:1683-1694.
68. Yin MJ, Yamamoto Y, Gaynor RB: The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(κ)B kinase-β. Nature 1998;396:77-80.